Patient question · asked by Anonymous reader · September 17, 2026
Does medical cannabis help with cancer pain? | CED Clinic
Does medical cannabis help with cancer pain and the general awfulness of advanced cancer?
Patient question: Does medical cannabis help with cancer pain and the general awfulness of advanced cancer? This is a very tricky question - with answers that keep changing with different papers and patient reports. For overall symptom burden, a recent randomized trial found no benefit beyond good palliative care - both groups improved by a.
The short answer
Dr. Caplan & CED Research Response
This is a very tricky question - with answers that keep changing with different papers and patient reports. For overall symptom burden, a recent randomized trial found no benefit beyond good palliative care - both groups improved by a similar amount. Pain specifically did improve more on cannabis, but alongside more psychological side effects, and general wellbeing was better on placebo. But, there are other papers on both sides of the isle that show sometimes it is very effective, sometimes not as much as placebo. Some of these differences might be attributable to study design, patient populations, other treatments going on - it's never quite simple.
A closer lookWhy the answer is what it is
The trial gave 144 patients with advanced cancer either a 1:1 THC:CBD oil or placebo for 28 days, on top of palliative care, and measured total symptom distress on the Edmonton Symptom Assessment Scale. At day 14, the two arms were indistinguishable: -6.30 versus -6.98 (P = 0.76).
The finding that both arms improved substantially is easy to skip past and worth sitting with. It says a good deal about what attentive palliative care achieves on its own.
Pain was the one place cannabis came out ahead (-1.42 versus -0.46; P = 0.04), and patients' own global impression of change favoured it too. The authors are careful to say that pain benefit came at the expense of greater psychomimetic toxicity. So the fair summary is narrow: possibly useful for pain, for some people, with a cost - and not the broad lifting of symptom burden that people often hope for.
The evidence
The study behind this answer
Verified on PubMed Randomized controlled trial
Medicinal Cannabis for Symptom Control in Advanced Cancer: A Randomised, Placebo-Controlled Trial of 1:1 THC and CBD
PubMed 40705150
Read the abstract as published
PURPOSE: Patients with cancer commonly access cannabis hoping to relieve their symptoms. This study assessed whether a 1:1 10 mg/ml THC:CBD combination oil could improve total symptom burden in patients with advanced cancer over that provided by palliative care alone.
METHODS: Participants were randomised to medicinal cannabis (MC) or placebo oil; dose escalated over 14 days according to tolerance and efficacy and continued to day 28. Symptoms assessed using the Edmonton Symptom Assessment Scale (ESAS) were summated to give a total symptom distress score (TSDS). The primary outcome measure was the change from baseline in TSDS at day 14. Secondary outcomes included individual symptom scores, opioid use, participant-selected dose, QoL, psychological symptoms, global impression of change (GIC), and adverse effects.
RESULTS: The pre-planned sample size of 120 at day 14 was reached following the randomisation of 144 patients. Mean (SD) TSDS improved over time in both arms (- 6.30 (12.3) MC, - 6.98 (12.56) placebo, p = 0.76) to day 14 with no difference between arms. A statistically significant improvement in ESAS pain scores in the MC arm (mean (SD) - 1.42 (2.15) MC and - 0.46 (2.83) placebo, p = 0.04) was at the expense of greater psychomimetic toxicity. Improvement in general well-being was greater for the placebo. GIC and the pain component of QoL both favoured MC.
CONCLUSIONS: Patients can be informed that a 1:1 THC:CBD combination cannabis oil was no better than palliative care alone in palliating symptoms in patients with advanced cancer. A small benefit in pain control was associated with greater toxicity.
TRIAL REGISTRATION: Australian New Zealand Clinical Trial Registry (ANZCTR): ACTRN12619000037101, 14/01/2019.
Abstract text as indexed by PubMed for this identifier.
In practice
What this study does and does not change
An honest negative result on the headline question. It is a useful corrective: people often arrive hoping cannabis will lift everything at once, and this trial says that is not what happened.
A physician's read of the cited study, as it appears on that study's page.
Back to Daily Research and Patient Questions
Reviewed by Dr. Caplan on September 17, 2026.
This answer is general education. It is not medical advice and does not create a doctor-patient relationship. For care specific to you, book a consultation. In an emergency, call 911.
